Related Experiment Video
Updated: May 9, 2026
11:38
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
Published on: July 2, 2016
Altering cell death pathways as an approach to cure HIV infection
A D Badley1, A Sainski, F Wightman
1Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. badley.andrew@mayo.edu
Cell Death & Disease
|July 13, 2013
Summary
Researchers propose targeting HIV apoptosis pathways to cure HIV infection. By promoting the death of all infected cells, combined with antiretroviral therapy (ART), a potential cure for HIV may be achievable.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Recent successes in controlling human immunodeficiency virus (HIV) through bone marrow transplant and early antiretroviral therapy (ART) suggest a potential cure.
- Current research focuses on gene therapy, immune boosting, inflammation reduction, and latency activation.
- A critical challenge is the dual nature of HIV infection: killing most CD4 T cells while others harbor latent virus resistant to ART.
Purpose of the Study:
- To propose targeting HIV apoptosis regulatory pathways as a novel strategy for achieving an HIV cure.
- To investigate mechanisms by which HIV induces apoptosis in infected cells.
- To explore how some cells evade the pro-apoptotic effects of HIV infection to inform new therapeutic approaches.
Main Methods:
- Reviewing existing literature on HIV pathogenesis, apoptosis, and latency.
- Analyzing observations from other viral systems regarding apoptosis resistance and viral persistence.
- Proposing a research agenda focused on understanding HIV-induced apoptosis and escape mechanisms.
Main Results:
- HIV infection leads to CD4 T cell death, but some cells survive and form a latent reservoir.
- Apoptosis resistance is linked to viral latency and persistence in other viral systems.
- Understanding HIV's manipulation of apoptosis pathways is key to developing curative strategies.
Conclusions:
- Targeting HIV apoptosis regulatory pathways offers a promising new avenue for an HIV cure.
- Inducing the death of all HIV-infected cells, including latent reservoirs, is a viable therapeutic goal.
- Further research into HIV-induced apoptosis mechanisms and cellular resistance is crucial for developing effective curative interventions.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.